OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002417-e002417
Open Access | Times Cited: 24
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002417-e002417
Open Access | Times Cited: 24
Showing 24 citing articles:
Humoral immune response to SARS-CoV-2 vaccines in patients with autoimmune rheumatic diseases
P. M. Corbalán, Rodrigo Hernán Tomas‐Grau, Mariana Pera, et al.
Archives of Medical Research (2025) Vol. 56, Iss. 3, pp. 103141-103141
Closed Access
P. M. Corbalán, Rodrigo Hernán Tomas‐Grau, Mariana Pera, et al.
Archives of Medical Research (2025) Vol. 56, Iss. 3, pp. 103141-103141
Closed Access
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
L. Mastromanno, Federico Giardina, Angelica Gattamelata, et al.
Reumatismo (2025)
Open Access
L. Mastromanno, Federico Giardina, Angelica Gattamelata, et al.
Reumatismo (2025)
Open Access
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
Hilde S Ørbo, K. H. Bjørlykke, Joseph Sexton, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003545-e003545
Open Access | Times Cited: 3
Hilde S Ørbo, K. H. Bjørlykke, Joseph Sexton, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003545-e003545
Open Access | Times Cited: 3
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
S. Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
S. Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Vaccination in the Era of Immunosuppression
Fatima Alnaimat, Jaleel Jerry G. Sweis, Jacqueline Jansz, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1446-1446
Open Access | Times Cited: 7
Fatima Alnaimat, Jaleel Jerry G. Sweis, Jacqueline Jansz, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1446-1446
Open Access | Times Cited: 7
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients
Zesheng An, Gabriel Figueroa‐Parra, Xian Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Zesheng An, Gabriel Figueroa‐Parra, Xian Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Should we stop methotrexate or not for vaccination?
Patrick Durez, Bernard Combe
RMD Open (2023) Vol. 9, Iss. 2, pp. e002798-e002798
Open Access | Times Cited: 5
Patrick Durez, Bernard Combe
RMD Open (2023) Vol. 9, Iss. 2, pp. e002798-e002798
Open Access | Times Cited: 5
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 725-733
Closed Access | Times Cited: 5
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 725-733
Closed Access | Times Cited: 5
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
The safety of COVID‐19 vaccination in immunocompromised children and young adults with immune‐mediated inflammatory disease
Benjamin Sahn, Ying Lu, Joyce Hui‐Yuen, et al.
Acta Paediatrica (2022) Vol. 112, Iss. 4, pp. 794-801
Open Access | Times Cited: 6
Benjamin Sahn, Ying Lu, Joyce Hui‐Yuen, et al.
Acta Paediatrica (2022) Vol. 112, Iss. 4, pp. 794-801
Open Access | Times Cited: 6
Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan
Yusuke Kashiwado, Yasutaka Kimoto, Kenji Oku, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 3, pp. 576-583
Open Access | Times Cited: 2
Yusuke Kashiwado, Yasutaka Kimoto, Kenji Oku, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 3, pp. 576-583
Open Access | Times Cited: 2
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis
Jennifer J. Lee, Sasha Bernatsky, Jeffrey C. Kwong, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 1, pp. 88-95
Open Access | Times Cited: 2
Jennifer J. Lee, Sasha Bernatsky, Jeffrey C. Kwong, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 1, pp. 88-95
Open Access | Times Cited: 2
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100221-100221
Open Access | Times Cited: 2
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100221-100221
Open Access | Times Cited: 2
Methotrexate and immunogenicity of vaccines in patients with rheumatic diseases
В. S. Belov, N. V. Muravyevа, Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 192-202
Open Access
В. S. Belov, N. V. Muravyevа, Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 192-202
Open Access
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: a scoping review of qualitative and quantitative evidence
Michaël Doumen, Lotte Diricks, Joppe Hermans, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152481-152481
Closed Access
Michaël Doumen, Lotte Diricks, Joppe Hermans, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152481-152481
Closed Access
Long Term Follow Up of Antibody Titres Against SARS-CoV-2 6 Months After Primary Protein Subunit COVID-19 Vaccination (ZF2001) in Indonesian Adults and Older Adults
Rodman Tarigan Girsang, Eddy Fadlyana, Kusnandi Rusmil, et al.
Open Access Journal of Clinical Trials (2024) Vol. Volume 16, pp. 41-48
Open Access
Rodman Tarigan Girsang, Eddy Fadlyana, Kusnandi Rusmil, et al.
Open Access Journal of Clinical Trials (2024) Vol. Volume 16, pp. 41-48
Open Access
Real world data on tolerability of COVID-19 vaccination in patients with rheumatoid arthritis based on patient reported outcomes
Martin Feuchtenberger, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology Advances in Practice (2024) Vol. 8, Iss. 4
Open Access
Martin Feuchtenberger, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology Advances in Practice (2024) Vol. 8, Iss. 4
Open Access
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)
J Geldof, Marie Truyens, João Sabino, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1157-1157
Open Access
J Geldof, Marie Truyens, João Sabino, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1157-1157
Open Access
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
Hilde S Ørbo, Taissa de Matos Kasahara, Asia‐Sophia Wolf, et al.
The Lancet Regional Health - Europe (2024) Vol. 48, pp. 101121-101121
Closed Access
Hilde S Ørbo, Taissa de Matos Kasahara, Asia‐Sophia Wolf, et al.
The Lancet Regional Health - Europe (2024) Vol. 48, pp. 101121-101121
Closed Access
Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review
Preeti Dhanasekaran, Biraveena Thirunavuc Karasu, Anselm Mak
Rheumatology International (2024)
Closed Access
Preeti Dhanasekaran, Biraveena Thirunavuc Karasu, Anselm Mak
Rheumatology International (2024)
Closed Access
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease
Amin Alirezaylavasani, Ingrid M. Egner, Benny Dahl, et al.
Clinical Immunology (2024), pp. 110404-110404
Open Access
Amin Alirezaylavasani, Ingrid M. Egner, Benny Dahl, et al.
Clinical Immunology (2024), pp. 110404-110404
Open Access
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients
Zesheng An, Xian Zhou, Yanfeng Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Zesheng An, Xian Zhou, Yanfeng Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Side effects of vaccines
Stephanie Tom-Brophy, Alexander Konopnicki, Andrew W. Ambler, et al.
Side effects of drugs annual (2023), pp. 303-335
Closed Access
Stephanie Tom-Brophy, Alexander Konopnicki, Andrew W. Ambler, et al.
Side effects of drugs annual (2023), pp. 303-335
Closed Access
Latent Class Analysis Identifies Distinct Phenotypes of Systemic Lupus Erythematosus Predictive of Flares after mRNA COVID-19 Vaccination: Results from the Coronavirus National Vaccine Registry for ImmuNe Diseases SINGapore (CONVIN-SING)
Tao Ming Sim, Manjari Lahiri, Margaret Ma, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 29-29
Open Access
Tao Ming Sim, Manjari Lahiri, Margaret Ma, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 29-29
Open Access
